Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,376 | 352 | 93.2% |
| Education | $612.91 | 7 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,721 | 112 | $0 (2024) |
| Janssen Biotech, Inc. | $1,875 | 106 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $666.48 | 6 | $0 (2023) |
| Lilly USA, LLC | $618.28 | 31 | $0 (2024) |
| GENZYME CORPORATION | $581.61 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $470.15 | 8 | $0 (2024) |
| Dermavant Sciences, Inc. | $348.43 | 6 | $0 (2024) |
| Amgen Inc. | $312.91 | 13 | $0 (2024) |
| UCB, Inc. | $259.13 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $225.02 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,613 | 93 | Janssen Biotech, Inc. ($622.87) |
| 2023 | $2,814 | 90 | Janssen Biotech, Inc. ($601.74) |
| 2022 | $2,336 | 97 | ABBVIE INC. ($942.02) |
| 2021 | $1,750 | 67 | AbbVie Inc. ($841.78) |
| 2020 | $475.14 | 12 | Janssen Biotech, Inc. ($146.69) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 15 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2020 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: Inflammation | ||||||
| 11/05/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Inflammation | ||||||
| 10/15/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Immunology | ||||||
| 10/09/2020 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 10/02/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology | ||||||
| 09/30/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 09/17/2020 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Inflammation | ||||||
| 07/22/2020 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Immunology | ||||||
| 06/08/2020 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 678 | 860 | $177,381 | $49,293 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $31,450 | $9,111 | 29.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 85 | 85 | $24,225 | $6,798 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 70 | $23,100 | $6,529 | 28.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 74 | 77 | $20,487 | $5,619 | 27.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 109 | 120 | $20,203 | $4,744 | 23.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 51 | 58 | $16,848 | $4,694 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 68 | $15,640 | $4,601 | 29.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 26 | 26 | $8,664 | $2,516 | 29.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 34 | 34 | $6,290 | $1,601 | 25.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 32 | $4,640 | $1,337 | 28.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 67 | 197 | $3,264 | $1,007 | 30.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 19 | $2,569 | $735.29 | 28.6% |
About Dr. Sterling Farrer, DO
Dr. Sterling Farrer, DO is a Internal Medicine healthcare provider based in Corvallis, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2017. The National Provider Identifier (NPI) number assigned to this provider is 1952836108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sterling Farrer, DO has received a total of $8,989 in payments from pharmaceutical and medical device companies, with $1,613 received in 2024. These payments were reported across 359 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($8,376).
As a Medicare-enrolled provider, Farrer has provided services to 678 Medicare beneficiaries, totaling 860 services with total Medicare billing of $49,293. Data is available for 1 year (2023–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology
- Location Corvallis, OR
- Active Since 04/25/2017
- Last Updated 08/04/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1952836108
Products in Payments
- TREMFYA (Drug) $2,353
- SKYRIZI (Biological) $1,351
- RINVOQ (Biological) $1,114
- DUPIXENT (Biological) $808.36
- TALTZ (Drug) $496.46
- VTAMA (Drug) $348.43
- COSENTYX (Drug) $313.56
- Otezla (Drug) $238.56
- Cimzia (Drug) $228.33
- Sotyktu (Drug) $225.02
- REMICADE (Biological) $188.70
- COSENTYX (Biological) $136.20
- HUMIRA (Biological) $124.28
- OLUMIANT (Drug) $100.80
- ARAZLO (Drug) $69.00
- ADBRY (Biological) $50.58
- ILUMYA (Biological) $48.79
- Enbrel (Biological) $48.64
- LIBTAYO (Biological) $39.99
- AMELUZ (Drug) $39.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Corvallis
Dr. Bo Wang, Md, MD
Internal Medicine — Payments: $169,270
Dr. Ashwat Dhillon, M.d, M.D
Internal Medicine — Payments: $159,083
Robin Mckelvey, Md, MD
Internal Medicine — Payments: $89,139
Jose Lozano Garcia, Md, MD
Internal Medicine — Payments: $27,271
Dr. Ross Downey, Md, MD
Internal Medicine — Payments: $3,115
Judy Shih, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $2,976